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Abstract
Objective
Analyze the measurement invariance and the factor structure of the Patient Health Ques-
tionnaire-9 (PHQ-9) in the Peruvian population.
Method
Secondary data analysis performed using cross-sectional data from the Health Question-
naire of the Demographic and Health Survey in Peru. Variables of interest were the PHQ-9
and demographic characteristics (sex, age group, level of education, socioeconomic status,
marital status, and area of residence). Factor structure was evaluated by standard confirma-
tory factor analysis (CFA), and measurement invariance by multi-group CFA, using stan-
dard goodness-of-fit indices criteria for interpreting results from both CFAs. Analysis of the
internal consistency (α andω) was also pursued.
Results
Data from 30,449 study participants were analyzed, 56.7% were women, average age was
40.5 years (standard deviation (SD) = 16.3), 65.9% lived in urban areas, 74.6% were mar-
ried, and had 9 years of education on average (SD = 4.6). From standard CFA, a one-dimen-
sional model presented the best fit (CFI = 0.936; RMSEA = 0.089; SRMR = 0.039). From
multi-group CFA, all progressively restricted models had ΔCFI<0.01 across almost all
groups by demographic characteristics. PHQ-9 reliability was optimal (α =ω = 0.87).
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Conclusions
The evidence presents support for the one-dimensional model and measurement invariance
of the PHQ-9 measure, allowing for reliable comparisons between sex, age groups, educa-
tion level, socioeconomic status, marital status, and residence area, and recommends its
use within the Peruvian population.
Background
Depression is currently one of the main causes of disability: an estimated 4.4% (322 million)
people around the world suffer from depression (5.1% of women and 3.6% of men) [1]. In
2017, prevalence of depressive symptomatology in North America, Latin America, and the
Caribbean was estimated at 15% (48.2 million) [1, 2]. In Peru, depression is the second greatest
cause of healthy years lost (7.4 in men and 13.7 in women) [3], and is on track to be the leading
cause of years lost to disability in 2030.[4] Thus, depression is a serious public health problem
requiring large-scale intervention [5]. Valid, brief, and reliable instruments to assess depressive
symptoms are also needed to guarantee appropriate monitoring of intervention effectiveness
[6]. In particular, the use of brief instruments for the early detection of depressive symptom-
atology appears to be cost-effective [7]. Likewise, comparing disease burden between groups
would help to establish priorities for social interventions [8].
Because depression is a latent construct and thus not strictly observable, instruments that
can evaluate the different indicators of the construct in diverse populations are necessary.
Depression instruments are commonly used for group comparisons (e.g., sex, age, or another
condition), but comparisons are only valid if the measurement invariance for an instrument is
established. For example, in the general population, an instrument of depression must identify
higher scores in depressive symptoms beyond inherent characteristics of the participants, and
also ensure that instrument items ‘point to’ the underlying experience of depression in similar
ways between men and women [9].
This similarity can be verified by considering the four stages of measurement invariance,
which require progressively stronger assumptions: configural, metric, strong and strict. Con-
figural invariance implies that the instrument has an equal factorial structure between groups,
i.e. the depression is measured with the same number of dimensions and items for each
dimension in both sexes. Metric invariance implies that the instrument items contribute in a
similar way in both groups, i.e. in men and women, items are equally meaningful indicators of
depression. Strong invariance implies that the intercepts (or, for ordinal items, thresholds) are
equivalent between both groups, or that the ‘set points’ for each item are similar between
groups. Finally, strict invariance suggests that the variance of the residual measurement error
for each item is equivalent in both groups [10].
Measurement invariance has been little studied in the Patient Health Questionnaire-9
(PHQ-9) [11], a self-administered version of PRIME-MD for common mental disorders that
evaluates each of the nine depression criteria from the DSM-IV [12] (these criteria are main-
tained in the DSM-V). Many population studies on depression have used the PHQ-9 for group
comparisons [13, 14]. However, because measurement invariance between groups has not
been evaluated in these studies, differences between groups may reflect measurement bias
rather than true differences in depression [10]. Without confirmed measurement invariance,
there is no warranty that PHQ-9 measures the construct in the same way across groups, mak-
ing any comparison hard to interpret [15].
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Evidence on the PHQ-9’s measurement invariance according to sex is less consistent than
in other group comparisons. Some studies support a strong invariance for sex comparisons
[11, 16, 17], whereas other studies report weak or even no measurement invariance across
sexes [18, 19], indicating that men and women could be interpreting the PHQ-9 items differ-
ently. In regard to other demographic variables, strong invariance has been evidenced across
races/ethnicities [11], age, marital status, and educational level [16]. However, there are no
studies on PHQ-9’s measurement invariance across urban/rural areas or socioeconomic status.
Despite this scant evidence, several studies make comparisons between these groups using the
PHQ-9 [13, 14]. Ultimately, the empirical evidence on the measurement invariance of the
PHQ-9 across these demographic characteristics is still insufficient.
Indeed, it remains unclear if the PHQ-9 is consistently one-dimensional as originally devel-
oped [20]. Some studies have found only one underlying dimension that summarizes depres-
sive symptoms as a whole [16, 18, 21]. However, depressive symptomatology is a multi-
dimensional construct which includes cognitive, emotional, social, sexual, and other disrup-
tions, and not all instruments have been designed for detecting and scaling each of its dimen-
sions [22]. Other studies have identified at least two dimensions in the PHQ-9, including
somatic, non-somatic or cognitive-affective dimensions [23–27]. Indeed, a recent systematic
review identified that evidence on the dimensional structure of the PHQ-9 is still inconclusive
[28]. Therefore, an important first step is to consider the dimensionality of the PHQ-9.
In view of the deficiencies in the evidence base relating to the PHQ-9’s psychometric prop-
erties, we sought to evaluate the measurement invariance of the PHQ-9 across groups by
selected demographic characteristics, following three steps: 1) identify the most appropriate
factor structure for the PHQ-9 in the Peruvian population (one-dimensional or two-dimen-
sional model); 2) to assess PHQ-9 measurement invariance by sex, age, education level, socio-
economic status, marital status and rural-urban area; and 3) to estimate the PHQ-9 reliability.
Materials and methods
Study design
A secondary data analysis was conducted using data from the Peruvian Demographic and
Health Survey (ENDES in Spanish), a nationally representative survey conducted annually.
Since 2014, the ENDES has included a Health Questionnaire that assesses different aspects of
health, such as mental health, oral health, and chronic diseases. Only cross-sectional informa-
tion from 2016 ENDES Health Questionnaire was used, which is available at the website of the
National Institute of Statistics and Informatics (INEI, in Spanish) [29].
ENDES design includes a two-stage random sampling technique, differentiated for rural
and urban areas. In rural areas, the primary sampling units were groups of 500–2000 individu-
als and the secondary sampling units were the households within each of these groups. On the
other hand, in urban areas, the sampling units consisted of blocks or groups of blocks with
more than 2,000 individuals and an average of 140 households, and the secondary sampling
units were the same as in rural settings [30].
Participants
The study sample was a representative sample of the Peruvian population, made up of men
and women, from urban and rural environments with multi-ethnic origins and different socio-
economic status in this middle-income country. Data from those aged�18 years were
included, but excluding people who had missing data in the variables of interest (sex, age
group, level of education, socioeconomic status, marital status, area of residence, and the nine
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items of PHQ). Initially there were 31,622 participants; however, after excluding participants
with incomplete information, data of 30,449 participants were analyzed (see Fig 1).
Measurements
The PHQ-9 is a Likert self-report consisting of nine items designed from the nine criteria eval-
uated by the DSM IV for major depression (MDD). PHQ-9 has four response options (0 = not
Fig 1. Flowchart of selected participants included in the study.
https://doi.org/10.1371/journal.pone.0221717.g001
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at all; 1 = several days; 2 = more than half the days; 3 = nearly every day), with scores ranging
from 0 to 27. This instrument reports the indicators of depressive symptomatology during the
last two weeks.[12] In other samples, the PHQ-9 has presented adequate levels of reliability
(α = 0.84) [31], and adequate levels of specificity (>0.90) but low sensitivity, between 0.39 and
0.73 [32].
Other variables were added to analyze the characteristics of the population as well as the
measurement invariance of the model. These variables were: sex, education level (primary edu-
cation [up to 6 years], secondary education [7–11 years] and superior [� 12 years]), age group
[33] (young [18 to 34], early adulthood [35 to 54], intermediate adulthood [55 to 74], and
older adults [� 75 years]), socioeconomic status (defined according to household assets and
then split in tertiles [low, medium and high]), marital status (married, never married and pre-
viously married), residence area (urban and rural) and natural region (coast, mountains and
jungle); the latest not used for measurement invariance analysis.
Statistical analysis
A polychoric correlation matrix was calculated using sampling weights and used for the subse-
quent analysis (see S1 Table). Subsequently, a confirmatory factor analysis determined the
dimensionality of the PHQ-9 in our target population. After identifying the number of dimen-
sions, the measurement invariance was assessed to establish the PHQ-9 equivalence across
groups by demographic characteristics. Finally, we performed the reliability analysis to deter-
mine the internal consistency of the PHQ-9 measures.
Confirmatory factor analysis. One-dimensional and two-dimensional measurement
models that have been shown to be feasible for the PHQ-9 [20, 23–25] were evaluated to iden-
tify optimal fit in the target population (see M1, M2, M3, and M4 in S1 Fig). The estimator
used was weighted least squares means and variance adjusted (WLSMV), which allows han-
dling non-normality in the confirmatory factor analysis (CFA) [34].
The adjustment of the models was evaluated through two successive steps. First, the Com-
parative Fit Index (CFI) and the Tucker-Lewis Index (TLI), both with appropriate values
�0.90; the Standardized Root Mean Square Residual (SRMR); and the Root Mean Square
Error of Approximation (RMSEA) with a confidence interval of 90%, and with adequate values
<0.08, were used to compare model fit [35, 36]. As a second and last step, the correlation
between the somatic and affective-cognitive dimension was evaluated (in the case of two-
dimensional models), since a very high correlation would indicate that both dimensions would
be overlapping. A clear differentiation between both dimensions can be considered when the
correlation is less than 0.80 [37].
Measurement invariance. Multiple models of the CFA measurement invariance were
evaluated through groups defined by relevant variables (sex, age group, education level, socio-
economic status, marital status, and residence area). Thus, four measurement models with
progressive restrictions were compared between categories of these groups (e.g. between
females and males) [10, 38]. Change in the CFI (ΔCFI) was used as the main criterion for com-
paring models with more restrictions against models with fewer restrictions. Simulation evi-
dence suggests that ΔCFI< .01 between successively more restricted models provides
evidence for measurement invariance [10]. Models first assumed configural invariance (i.e.
similar factor structure across groups) as the base model, progressing to metric invariance (i.e.
similar factor loadings and factor structure across groups), strong invariance (i.e. similar
thresholds, factor loadings and factor structure across groups), and strict invariance (i.e. simi-
lar residual item variances, thresholds, factor loadings and factor structure across groups).
Between each model, the ΔCFI was examined to establish if the more restricted model was
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appropriate. We preferred ΔCFI over χ2 comparisons, since the first is not sensitive to big sam-
ple sizes [10, 38].
Reliability. Reliability analyses were performed using the classic alpha (α) and categorical
omega coefficient (ω), which optimal values are> 0.80, and the item-test correlation which
optimal values are >0.20 [39–41].
All analyses were done in R Studio, with the packages “lavaan” [42], “lavaan.survey” [43],
“semTools” [44], and “semPlot” [45].
Results
Participants characteristics
The sample consisted of men (n = 13,196, 43.3%) and women (n = 17,253, 56.7%), the ages
ranged from 18 to 98 years old, the mean age was 40.5 (SD = 16.3) and on average, participants
had 9 years of education (SD = 4.6) (see Table 1). Likewise, the participants of our study are
compared with the results of the last Peruvian census (see S2 Table).
Confirmatory factor analysis
It was identified that the models of one and two dimensions present adequate indexes of good-
ness-of-fit (see S3 Table). However, the correlations between the dimensions in the two-factor
models (somatic and cognitive-affective) ranged between 0.97 and 0.99. Therefore, the one-
dimensional model was carried forward for measurement invariance testing (see Fig 2).
Measurement invariance
The values of ΔCFI were <0.01 when all models, with progressive restrictions, were compared
across age groups, sex, level of education, socioeconomic status, marital status, and residence
area (see Table 2). All groups reported strict invariance.
Reliability
The reliability of the PHQ-9 scores was high, reaching coefficients of internal consistency of
α = 0.870 and ω = 0.873. On the other hand, the item-test correlation fluctuated between 0.62
and 0.77 (see Table 3).
Discussion
Main findings
The PHQ-9 showed consistently good measurement invariance, allowing comparisons
between groups by age, sex, educational level, socioeconomic status, marital status, and resi-
dence area. Measurement invariance provides confidence that any difference between PHQ-9
one-dimension measures across these groups comes from a real difference in depressive symp-
tomatology and not from group-specific properties of the instrument itself. Additionally, our
evidence supported an optimal reliability of PHQ-9.
Factorial structure
Though goodness-of-fit indices indicated that two-dimensional models fit the data better than
the one-dimensional model, the correlation between these two factors ("somatic" and "cogni-
tive-affective") was consistently very high across all models (.967 to .988). This indicates a sub-
stantial overlap between the two factors, complicating the interpretation of the results of the
test [37], and pointing to the value of a more parsimonious unidimensional solution. It should
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be noted that the single-factor model is the most studied and used in applications of the PHQ-
9 [28, 32], and indeed that the PHQ-9 was designed as a one-dimensional screening tool to
evaluate the nine DSM diagnostic indicators [11]. Other evaluation instruments, such as the
Beck Depression Inventory (BDI-II) and the Center for Epidemiological Studies Depression
scale (CES-D), consider that depression is a multidimensional construct and evaluate addi-
tional items of sexual problems, indecision, self-criticism, feelings of anxiety, among others.
These instruments’ additional dimensions does not imply that the PHQ-9 collects partial
information on the construct, since these additional indicators are not part of the main diag-
nostic criteria for major depression disorder. Several studies conducted in the general popula-
tion and primary care support the one-dimensional model of the PHQ-9. For instance, a study
in primary care centers in Spain (n = 836), in primary care patients with different ethnic ori-
gins and risk of depression from the Netherlands (n = 1,772), and another in the general popu-
lation of Hong Kong (n = 6,028), coincide with our findings that the one-dimensional model
of the PHQ-9 is the most parsimonious and stable [16, 18, 21].
However, two studies in American samples have found two dimensions: one study using a
representative sample (n = 26,202) and one study in a sample of soldiers (n = 2,615) [11, 26].
Yet the relationship between the two factors was very high (0.87 in both cases). Both studies
coincide with our results, suggesting an overlap between both dimensions. On the other hand,
a German study in patients with major depression (n = 626) and another in cancer patients
with palliative care from the UK (n = 300) [25, 27], identified the somatic and affective-cogni-
tive dimensions as related but distinct, with a correlation between the latent dimensions of
0.58 and 0.30, respectively. A possible explanation for the heterogeneity of the results on the
internal structure of the PHQ-9 is the population evaluated. Investigations that report a clear
Table 1. Characteristics of the participants included in the study.
Overall Men Women
N % n % n %
Score in PHQ-9 0 to 9 28,077 92.2% 12,556 95.2% 15,521 90.0%
10 to 14 1,438 4.7% 450 3.4% 1,043 6.0%
15 to more 934 3.1% 190 1.4% 689 4.0%
Age 18–34 13,576 44.6% 5,404 41.0% 8,172 47.4%
35–54 10,739 35.3% 4,946 37.5% 5,793 33.6%
55–74 4,791 15.7% 2,242 17.0% 2,549 14.8%
75+ 1,343 4.4% 604 4.5% 739 4.3%
Education level Up to 6 years 10,314 33.9% 4,353 33.0% 5,961 34.5%
7–11 years 12,152 39.9% 5,394 40.9% 6,758 39.2%
12+ years 7,983 26.2% 3,449 26.1% 4,534 26.3%
Socioeconomic status Lowest 10,280 33.8% 4,575 34.7% 5,705 33.1%
Middle 10,213 33.5% 4,347 32.9% 5,866 34.0%
Highest 9,956 32.7% 4,274 32.4% 5,682 32.9%
Marital status Married 22,702 74.6% 10,410 78.9% 12,292 71.3%
Never married 2,901 9.5% 1,293 9.8% 1,608 9.3%
Previously married 4,846 15.9% 1,493 11.3% 3,353 19.4%
Natural region Coastal 12,335 40.5% 5,349 40.5% 6,986 40.5%
Highlands 10,770 35.4% 4,524 34.3% 6,246 36.2%
Jungle 7,344 24.1% 3,323 25.2% 4,021 23.3%
Residence area Urban 20,066 65.9% 8,524 64.6% 11,542 66.9%
Rural 10,383 34.1% 4,672 35.4% 5,711 33.1%
https://doi.org/10.1371/journal.pone.0221717.t001
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differentiation between the somatic and cognitive-affective dimensions predominantly draw
on clinical populations [25, 27], whereas those that report an overlap between both dimensions
are performed in the general population [11, 26]. Living several years with depression or with
a chronic disease that significantly affects physical health could cause people to differentiate
physical or somatic indicators from those affective-cognitive. For example, it is possible that
cancer patients might have a high score on the items on sleep disturbance, fatigue, and appetite
changes (often associated with the somatic dimension), because these are side effects of
Fig 2. Factorial structure of Patient Health Questionnaire-9 (two weeks). Note: The circular figure indicates a latent variable; the figure of the rectangles indicates
observed variables (items); λ = standardized factor loads; θ = error variance; CFI and TLI = comparative adjustment index considers optimal values�0.95;
SRMR = Mean root of standardized error considers adequate values<0.08; RMSEA = Mean root of the approximation error considers appropriate values<0.08.
https://doi.org/10.1371/journal.pone.0221717.g002
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treatment, but score low on cognitive-affective items. This would diminish the correlation
between the two dimensions and give rise to the appearance of differentiation. In terms of
behavior, the dimensionality of the detection of depressive symptoms would be mediated by
Table 2. Measurement invariance in the Patient Health Questionnaire-9 (two weeks) for the different groups.
Group Invariance x2(df) CFI RMSEA Δ x2(Δ df) ΔCFI Δ RMSEA
Sex Configural 5284.4 (54)��� 0.974 0.080 [0.078–0.082] - - -
Metric 4221.0 (62)��� 0.980 0.066 [0.065–0.068] 16.8 (8) 0.005 0.013
Strong 5408.9 (71) ��� 0.974 0.070 [0.069–0.072] 38.3 (9) 0.006 0.004
Strict 4516.0 (80) ��� 0.978 0.060 [0.059–0.062] 54.4 (9) 0.004 0.010
Age Configural 5297.4 (108)��� 0.974 0.079 [0.078–0.081] - - -
Metric 3708.9 (132)��� 0.982 0.060 [0.058–0.061] 35.2 (24) 0.008 0.020
Strong 5489.2 (159)��� 0.973 0.066 [0.065–0.054] 2.9 (27) 0.009 0.017
Strict 4595.7 (186)��� 0.978 0.056 [0.054–0.057] 137.3 (27) 0.005 0.011
Education Configural 5111.9 (81)��� 0.976 0.078 [0.076–0.080] - - -
Level Metric 3707.6 (97)��� 0.983 0.061 [0.059–0.062] 22.8 (16) 0.007 0.017
Strong 5165.1 (115)��� 0.976 0.066 [0.064–0.067] 34.9 (18) 0.007 0.005
Strict 4007.8 (133)��� 0.982 0.054 [0.052–0.055] 32.4 (18) 0.006 0.012
Socioeconomic Configural 5163.9 (81)��� 0.976 0.079 [0.077–0.080] - - -
Status Metric 3732.4 (97)��� 0.983 0.061 [0.059–0.062] 19.3 (16) 0.007 0.018
Strong 5227.9 (115)��� 0.976 0.066 [0.065–0.068] 18.4 (18) 0.007 0.005
Strict 4244.7 (133)��� 0.981 0.055 [0.054–0.057] 109.0 (18) 0.005 0.011
Marital status Configural 5171.3 (81)��� 0.975 0.079 [0.077–0.081] - - -
Metric 3678.5 (97)��� 0.982 0.060 [0.059–0.062] 26.2 (16) 0.007 0.018
Strong 5159.9 (115)��� 0.975 0.066 [0.064–0.067] 43.3 (18) 0.007 0.005
Strict 3960.5 (133)��� 0.981 0.053 [0.052–0.055] 42.3 (18) 0.006 0.012
Residence area Configural 5252.9 (54)��� 0.975 0.080 - - -
(rural/urban) Metric 4223.0 (62)��� 0.980 0.066 20.0 (8) 0.005 0.013
Strong 5453.0 (71)��� 0.975 0.071 30.6 (9) 0.006 0.004
Strict 4542.0 (80)��� 0.979 0.061 58.5 (9) 0.004 0.0!0
Note
��� = p < .001; the results correspond to the one-dimensional model (M1).
https://doi.org/10.1371/journal.pone.0221717.t002
Table 3. Descriptive measures and item-test correlation of the items in the Patient Health Questionnaire-9 (two weeks).
Items SE M (CI 95%) SD g1 g2 ritc
1. Anhedonia 0.004 0.48 (0.49–0.47) 0.77 1.74 5.59 0.729
2. Depressed mood 0.005 0.53 (0.54–0.52) 0.81 1.60 5.03 0.774
3. Sleep disturbance 0.004 0.39 (0.40–0.39) 0.78 2.11 6.77 0.708
4. Fatigue 0.004 0.35 (0.36–0.35) 0.70 2.24 7.80 0.753
5. Appetite changes 0.004 0.31 (0.32–0.30) 0.70 2.49 8.82 0.679
6. Feelings of worthlessness 0.003 0.20 (0.21–0.20) 0.57 3.32 14.50 0.668
7. Concentration difficulties 0.004 0.28 (0.29–0.27) 0.64 2.63 10.00 0.703
8. Psychomotor disturbances 0.004 0.26 (0.26–0.25) 0.62 2.80 10.94 0.718
9. Thoughts of death 0.003 0.14 (0.14–0.13) 0.48 4.16 21.80 0.636
Total 0.024 2.95 (3.00–2.90) 4.33 2.16 8.62 -
Note:SE = standard error; M = Mean; SD = standard deviation; g1 = skewness; g2 = kurtosis; rit = item-test correlation; the results correspond to the one-dimensional
model (M1).
https://doi.org/10.1371/journal.pone.0221717.t003
Valid group comparisons can be made with the Patient Health Questionnaire (PHQ-9)
PLOS ONE | https://doi.org/10.1371/journal.pone.0221717 September 9, 2019 9 / 15
contingencies associated with physical comorbidity [16]. Finally, it is possible that cultural fac-
tors play a role in whether the depressive symptomatology is perceived as a single construct, or
as two related elements (somatic and cognitive-affective) [46]. However, it is not possible to
identify what might be the psychological mechanisms that would generate an overlap between
the two dimensions in these culturally different studies.
Likewise, it is necessary to point out the practical disadvantages generated by having a
model of two subdimensions instead of a one-dimensional model. In addition, the original
qualification method is based on a one-dimensional model that sum up the direct scores of all
items.[12] It should be noted that the original cutoff points for determining levels of morbidity
(�5,�10,�15 and�20) have proven to be more appropriate compared to alternative classifi-
cation methods [32].
Measurement invariance
Our results support that the PHQ-9 presents convincing measurement invariance in the
groups of age, sex, educational level, socioeconomic status, residence area, and marital status,
allowing meaningful group comparisons. Other studies, in university students from the United
States (n = 857) and primary care in Spain (n = 836), support our results as they report strong
measurement invariance according to sex [16, 17]. On the other hand, a study in primary care
patients at high risk of depression in the Netherlands identified that the measurement invari-
ance at the level of factor loadings was violated [18] because women presented higher loadings
for "sleep disturbance" and men for "loss of interest". These results suggest that the measure-
ment invariance between men and women is not met in a population at high risk of depression
or depression. That is to say, as the depressive symptomatology increases, the differences
between both sexes accrue, meaning that women and men tend to score higher in a different
group of items (i.e. sleep disturbance and loss of interest). Different studies also report that the
prevalence of sleep and appetite problems is greater in women than in men [47, 48]. Our
results support that it is possible to make comparisons between men and women in the Peru-
vian population. Similarly, accumulated international evidence supports the possibility of
making comparisons between men and women using the one-dimensional model in the gen-
eral population [49].
Our results support the presence of a strong invariance according to the age, educational
level, and marital status, allowing comparisons between groups in the Peruvian population. A
Spanish study conducted in a small group of primary care patients also found strong invari-
ance between age groups, marital status, and educational level [16]. At the level of measure-
ment invariance between age groups, there is evidence that depression among young people
and older adults is qualitatively different, in addition to the fact that older adults have a higher
prevalence of depressive symptoms [48]. However, this does not seem to affect the factor struc-
ture or how they understand the construct. With respect to measurement invariance by educa-
tional level and marital status, it is not possible to identify a plausible psychological or
biological mechanism that could justify a possible violation of invariance. However, these ana-
lyzes are necessary because of their impact on practice since several studies make comparisons
between these groups [13, 14]. Our results, like those developed in the Spanish study, support
making comparisons validity between age, educational level, and marital status.
The present study supports the possibility of making comparisons between socioeconomic
status and area of residence (urban and rural); however, our results could not be compared
with other studies since no other research was found that evaluated the measurement invari-
ance according to these groups using the PHQ-9. Despite the limited evidence on measure-
ment invariance in these groups, different studies have already made comparisons between the
Valid group comparisons can be made with the Patient Health Questionnaire (PHQ-9)
PLOS ONE | https://doi.org/10.1371/journal.pone.0221717 September 9, 2019 10 / 15
direct scores of the PHQ-9 in people from urban and rural areas, as well as between people of
different socioeconomic status [14]. Theories of social disadvantage and structural determi-
nants of health could explain a possible difference between direct scores, due to limited access
to opportunities and limited access to specialized health services [50].
Reliability
Our results present optimal reliability coefficients of the scores derived from the measure of
the PHQ-9 in the Peruvian population. This is consistent with other findings in the literature.
In particular, two studies with a similar sample size carried out in the general population of
China [21] and Germany [20], identified very similar values of internal consistency (classical
alpha) of 0.82 and 0.86, respectively. Therefore, despite being studies in culturally different
populations, the measurements of depression symptoms using the PHQ-9 present a similar
internal consistency. Some differences in the characteristics of the participants of the ENDES
and the Peruvian census of 2017 are identified, especially in the level of education, marital sta-
tus, natural region, and area of residence. This may be because ENDES was originally designed
to be representative of women of fertile age. This would be generating that the characteristics
of the participants differ between ENDES and the Peruvian census. It should be noted that this
should not affect the conclusions of the study.
Relevance in public health
The PHQ-9 is one of the instruments most used by researchers and mental health professionals
around the world to evaluate depressive symptoms [32]. Within its applications in public
health, its use is recommended to evaluate depressive symptomatology in clinical trials and
research in general [24, 32], since it is an instrument with solid evidence of validity and reli-
ability. Likewise, different countries promote its use in primary care [51, 52], owing to its brev-
ity, easy scoring (add the nine items), and applicability across heterogeneous
sociodemographic characteristics. Our results support the use of the Spanish version of the
PHQ-9 in the Peruvian population. These evidences suggest that it is possible to use the PHQ-
9 in other Spanish-speaking countries in Latin America.
Strengths and limitations
Among the strengths of the study are the large sample size and the representativeness of the
study sample. This is the only study reported in Latin America that evaluates the measurement
invariance of PHQ-9. However, the study is not free of limitations. Our results and conclusions
are focused on the Peruvian population, so, results can be extrapolated with caution towards
potentially similar populations. Additionally, neither the inter-rater effect (different level of
experience of the interviewers) nor the inter-family effect (participants from the same family
group) was controlled. However, this should not change our results, since all the evaluators
received intensive training for several weeks before conducting the evaluations, so it is
expected that such training will homogenize the evaluation process and gather information
[30]. On the other hand, it is expected that although there are cases where two or more partici-
pants belong to the same family group, this number should be minimal compared to the total
evaluated. Despite these limitations, our results are still valid and reliable.
Conclusions
The evidence presents support for the one-dimensional model and measurement invariance of
the PHQ-9 measure, allowing for reliable comparisons between sex, age groups, education
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level, socioeconomic status, marital status, and residence area, and recommends its use within
the Peruvian population.
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